CARM Stock Earnings: CARISMA Therapeutics Beats EPS, Beats Revenue for Q4 2023

InvestorPlace - Stock Market News, Stock Advice & Trading Tips

CARM stock results show that CARISMA Therapeutics beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023.

The post CARM Stock Earnings: CARISMA Therapeutics Beats EPS, Beats Revenue for Q4 2023 appeared first on InvestorPlace.

• The #1 AI Investment Might Be This Company You’ve Never Heard Of
• Musk’s “Project Omega” May Be Set to Mint New Millionaires. Here’s How to Get In.
• It doesn’t matter if you have $500 or $5 million. Do this now.